Point72 Asset Management, L.P.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1603466
STAMFORD, CT
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,303,916
+$1,303,916 QoQ
Shares Held
2,625
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#785
of 1,735 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Jun 30, 2026CallValue
$7,152,912
CallShares
14,400
PutValue
$794,768
PutShares
1,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. VRTX ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $794,768 | 1,600 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,303,916 | 2,625 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $7,152,912 | 14,400 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,607,544 | 3,600 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $7,412,564 | 16,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $9,520,560 | 21,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $3,218,856 | 7,100 | Put | Defined | 2026-02-17 | |
| 2024-12-31 | $8,054,000 | 20,000 | Put | Defined | 2025-02-14 | |
| 2023-09-30 | $29,701,864 | 85,414 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $86,724,348 | 246,439 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $81,445,595 | 258,500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $32,008,086 | 110,839 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $31,096,596 | 107,400 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $10,452,960 | 47,600 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $13,408,395 | 66,500 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $142,681,157 | 663,973 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $52,727,454 | 223,100 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $35,430,024 | 130,200 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||